搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Masala
1 天
Men’s Health Alert! Here’s how winter is impacting prostate health and triggers urinary ...
Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...
2 天
on MSN
Winter and risk of prostate problems in men over 60: What’s the connection? Urologist ...
Cold weather can trigger frequent urination, hormonal changes and diuresis, especially in men over the age of 60.
2 天
FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
healthday
3 天
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...
Renal & Urology News
6 天
Gemtesa Approved for Men With OAB Symptoms Receiving BPH Treatment
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
来自MSN
6 天
12 Things Your Bladder Secretly Wants to Tell You
Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...
The Financial Express
6 天
What every men need to know about UTI and incontinence?
Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...
Rolling Out
9 天
Male urination issues can be solved early
Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.
MedPage Today
12 天
Bill Clinton Hospitalized; Lower Cost Ozempic? WHO Withdrawal Planned
And Alcon Laboratories issued a voluntary nationwide recall of certain Systane Lubricant Eye Drops due to fungal ...
The Pharma Letter
12 天
Sumitomo gains FDA approval of Gemtesa for OAB
The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...
ENDPOINTS NEWS
13 天
Sumitomo’s overactive bladder drug adds another indication
Sumitomo Pharma’s oral treatment for overactive bladder symptoms has won an expanded label from the FDA, and is now approved ...
verywellhealth
14 天
What Is the Best Medication for Overactive Bladder?
Overactive bladder (OAB) is a group of symptoms that are not usually life-threatening but can significantly decrease productivity and quality of life. The condition is characterized by the sudden need ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈